Skip to main content
SpringerLink
Log in

Alendronic acid increases risk of atrial fibrillation in women

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Heckbert SR, Li G, Cummings SR, Smith NL, Psaty BM.Use of alendronate and risk of incident atrial fibrillation in women. Archives of Internal Medicine 168: 826-831, No. 8, 28 Apr 2008

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Alendronic acid increases risk of atrial fibrillation in women. React. Wkly. 1202, 4 (2008). https://doi.org/10.2165/00128415-200812020-00010

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200812020-00010

Keywords

Search

Navigation